Parshall B Lynne's Form 4 filing
Cytokinetics Inc (CYTK) · filed Sep 1, 2022
- Accession no.
- 0001127602-22-021932
- Filed
- Sep 1, 2022
- Trade date
- Sep 1, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.60M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parshall B LynneCIK 0001073385 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Common Stock | MOption exerciseAcquired | +5,714 | $8.75 | +$49,997.5 | 15,714 | Direct | |
| Sep 1, 2022 | Common Stock | MOption exerciseAcquired | +20,000 | $9.45 | +$189,000 | 35,714 | Direct | |
| Sep 1, 2022 | Common Stock | MOption exerciseAcquired | +4,582 | $6.82 | +$31,249.24 | 40,296 | Direct | |
| Sep 1, 2022 | Common Stock | SSaleDisposed | −30,296 | $52.79 | −$1,599,325.84 | 10,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Common Stock | MOption exerciseDisposed | −5,714 | $0.00 | $0 | 0 | Direct | |
| Sep 1, 2022 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Sep 1, 2022 | Common Stock | MOption exerciseDisposed | −4,582 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.